Subscribe

DCI Blog

All
All

Duke Cancer Institute (DCI) Blog provides updates, organizational announcements, the latest in funding opportunities and information on upcoming conferences and symposiums. This blog also highlights inspiring patient stories and the accomplishments and achievements of DCI faculty and staff. Subscribers are invited to submit story ideas and other news of interest. Email submissions and feedback to Karen E. Butler, Director of Communications, Duke Cancer Institute.

Bone Scan Software Accurately Calculates Prognosis of Advanced Prostate Cancer

andrewarmstrong.jpg A software tool to automatically calculate how extensively bones have been infiltrated by prostate cancer is both accurate and speedy, capturing key prognostic information related to survival and the development of symptoms over time. The software, called the automated bone scan...

Myeloma Specialist To Pedal Across England And France

Cristina Gasparetto , MD, hematologic malignancies and cellular therapy specialist, has signed on to participate in the road to Victories London to Paris Ride, a challenge event supporting the Multiple Myeloma Research Foundation’s (MMRF) mission to fund myeloma research leading to better...

Deadly Cancers Show Early, Detectable Differences from Benign Tumors

Do metastatic cancer tumors “break bad” or are they “born bad”? This question is an essential mystery in cancer early detection and treatment. Lacking a clear answer, patients are given the same aggressive therapies when small, abnormal clusters of cells are discovered early, even though they might...

New Advances in Overcoming Prostate Cancer Disparities

African American men are nearly two times more likely to develop prostate cancer than white men and nearly three times more likely to die from the disease. In North Carolina, the rate of prostate cancer-related deaths among African Americans is higher than the national average. Researchers at the...

May Newsmakers

Read here for a sample of some of the DCI physicians, physician-scientists, researchers and nurses whose work is featured in the media and academic journals this month. This list includes John Sampson, MD, PhD; Daniel George, MD; Angeles Alvarez Secord, MD; Ravi Bellamkonda, PhD; and many others.

McDonnell Team Awarded $7 Million For Breast Cancer Study

A team of researchers led by Duke Cancer Institute scientist Donald McDonnell, PhD, has been awarded a Breast Cancer Research Program (BCRP) Innovator Award, totaling $7,368,485, by the United States Department of Defense Office of Congressionally Directed Medical Research Programs (CDMRP). The...

Seed Funds Awarded For Financial Toxicity Study

Duke Cancer Institute radiation oncologists Yvonne Mowery, MD, PhD; David Brizel, MD; and Fumiko Chino, MD; have been granted $50,971 in seed funding by the Radiation Oncology Institute (ROI) (affiliated with the American Society for Radiation Oncology) for their forthcoming study evaluating...

Salama Named Director Of Melanoma Program

April Salama, MD, previously interim director of Duke Cancer Institute’s Melanoma Program, was recently named director of the program. Since assuming the role as interim director three years ago, Salama has advanced the melanoma program at Duke Cancer Institute. "Dr. Salama continues to expand the...

Research Award Established In Honor Of DCI Executive Director

In 2002 the American Association for Cancer Research (AACR) launched Molecular Cancer Research ( MCR ) appointing Michael B. Kastan, MD, PhD, to the helm as the publication’s founding editor-in-chief. Kastan, executive director of Duke Cancer Institute, is recognized as having attracted scientific...

Aptamers May Form New, Safer Chemotherapy Delivery Systems

Using chemotherapy along with aptamers—lab-made molecules that function like antibodies—Duke Health researchers showed that they can zero in on and kill prostate cancer tumors in mice while leaving healthy tissue unscathed. The finding suggests that aptamers could form the basis of new cancer...

Researchers Make Progress Unlocking Breast Brain Metastasis

Each year nearly 150,000 Americans are diagnosed with metastatic cancer that has spread to the brain. The number is projected to rise. As a result of a larger aging population, combined with improvements in cancer screening and care, up to 30 percent of patients with solid tumor cancers can expect...

McDonnell Named Komen Scholar, Joins Board

The Susan G. Komen Foundation recently announced the selection of 10 new members to the national Komen Scholars program, including Donald McDonnell, PhD, professor and chairman of Pharmacology and Cancer Biology and the Glaxo-Wellcome professor of Molecular and Cancer Biology. “It is a great honor...

Pages